Immunic reported $38.36M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Cipla INR 70.14B 7.16B Mar/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.04M 533K Mar/2026
CSL USD 4.61B 207M Dec/2025
Enanta Pharmaceuticals USD 44.73M 3.83M Dec/2025
Grifols EUR 2.37B 156.97M Dec/2025
Immunic USD 38.36M 7.74M Mar/2026
Insmed USD 361.01M 107.87M Mar/2026
Omeros USD 85.5M 2.28M Jun/2025
OraSure Technologies USD 44.08M 4.29M Mar/2026
Quidel USD 962.4M 3.7M Mar/2026
Ultragenyx Pharmaceutical USD 325M 59M Mar/2026
United Therapeutics USD 599.1M 38.5M Mar/2026